CAMBRIDGE, MA (October 18, 2004) – Researchers at Millennium Pharmaceuticals, Inc. and the
WASHINGTON, DC (October 18, 2004) – The Food & Drug Administration (FDA) said Friday that none of the influenza vaccine manufactured by Britain’s Chiron Corp. for the US market is safe for use.
WASHINGTON, DC (October 18, 2004) – The Food & Drug Administration (FDA) last week directed
NEW YORK, NY (October 18, 2004) –Although New York is known as “the city that never sleeps,” a just-released study ranked Detroit as the worst city in America for shuteye. New York came in slightly better, ranking sixth on the bad-slumber list.
LONDON (October 18, 2004) – With expansion of biopharmaceuticals expected to be driven by reduced efficacy of existing drugs and a lack of treatments for new diseases, an international market consultancy has called for increased emphasis on downstream processing.
Reducing Risk and Lowering Costs in an Outsourced Manufacturing Model By Michael Webster, Director of Life Sciences, Ross Systems Outsourced manufacturing has exploded in the last 20 years to become a standard for companies ranging from emerging biopharmas to the global pharmaceuticals.
REDWOOD CITY, CA (October 12, 2004) – Codexis, Inc. announcedthis week that Peter Ketelaar has joined the company as director of businessdevelopment, Europe.
WASHINGTON, DC (October 12, 2004) – The Food & Drug Administration (FDA) has informed Hillestad Pharmaceuticals, USA, Inc., of Woodruff, Wisconsin, that the firm is violating a court order prohibiting the company from using drug claims in the promotion of its dietary supplement products.
PHOENIX, AZ (October 12, 2004) – Honeywell last week announced a definitive agreement to acquire the intellectual property of the HYSYS modeling software and the Operator Training Simulation (OTS) business from Aspen Technology Inc.
BETHEL, CT (October 12, 2004) – Memry Corp. announced last week that it has entered into an exclusive distribution agreement with Assured Automation for distribution of its Firechek valves throughout North America.
SAN DIEGO, CA (October 12, 2004) – ChemBridge Corp. and the University of Hong Kong recently
WASHINGTON, DC (October 4, 2004) -- The Food & Drug Administration (FDA) last week acknowledged the voluntary withdrawal from the market of Vioxx (chemicalname rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufacturedby Merck & Co.
CHICAGO, IL (October 4, 2004) – In the health services field, wherequality of care and attention to detail are essentials, workers continue tostruggle with managing growing workloads, according to a survey released this week by CareerBuilder.com.
BRANFORD, CT (October 4, 2004) – Cellular Genomics Inc. (CGI), a chemical genetics-based drug discovery and development company, has announced that Udo Klein, Ph.D. has joined the company in the newly created position of senior vice president of drug development Klein, who will report to Louis A.